Stealth BioTherapeutics Inc. (Stealth Bio), a clinical-stage biotech innovator specializing in mitochondrial medicine, has announced a major regulatory milestone: the U.S. Food and Drug Administration (FDA) has granted accelerated approval for FORZINITY™ (elamipretide HCl). This novel therapy is now authorized to improve muscle strength in... Continue reading